NIH-funded research Fellowship grant

Understanding how NPC1 protein functions in human brain cells

Official title: Investigating mechanisms of NPC1 proteostasis in human neurons

Funded at University of Michigan at Ann Arbor · NIH-10998266 · Data updated 2026-11-12

This study is looking at how changes in the NPC1 protein affect brain cells in people with Niemann-Pick disease type C, with the hope of finding new ways to help treat this condition by understanding how cholesterol is moved in cells.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJuly 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$41,925
NIH project number1F31NS135634-01A1
Project IDNIH-10998266 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Niemann-Pick disease type C, particularly those with mutations in the NPC1 gene.

Less likely to help

Patients with other forms of Niemann-Pick disease or those without NPC1 mutations may not benefit from this research.

What this research studies

This research investigates the mechanisms behind the NPC1 protein's stability and function in human neurons, particularly in the context of Niemann-Pick disease type C, a genetic disorder that leads to severe neurological issues. The study focuses on how mutations in the NPC1 gene affect the protein's ability to transport cholesterol within cells, which is crucial for maintaining cellular health. By using advanced techniques like CRISPR, the researchers aim to identify the factors that influence NPC1's proper folding and trafficking, which could lead to new therapeutic strategies for patients. The findings could provide insights into whether treatments that work in skin cells can also be effective in brain cells, which are significantly impacted in this disease.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve neurological function in patients with Niemann-Pick disease type C.

How similar studies have gone: Previous research has shown promise in targeting NPC1 protein homeostasis in fibroblasts, but this approach in neurons is relatively novel and untested.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Azaria, Ruth D. — University of Michigan at Ann Arbor
  • Study coordinator: Azaria, Ruth D.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.